Litcius/Paper detail

Effect of SGLT2 Inhibitors on Cardiovascular Outcomes Across Various Patient Populations

Muhammad Usman, Tariq Jamal Siddiqi, Stefan D. Anker, George L. Bakris, Deepak L. Bhatt, Gerasimos Filippatos, Gregg C. Fonarow, Stephen J. Greene, James L. Januzzi, Muhammad Shahzeb Khan, Mikhail Kosiborod, Darren K. McGuire, Ileana L. Piña, Julio Rosenstock, Muthiah Vaduganathan, Subodh Verma, Shelley Zieroth, Javed Butler

2023Journal of the American College of Cardiology136 citationsDOI

Topics & Concepts

MedicineHeart failureInternal medicineEjection fractionKidney diseaseDapagliflozinPlaceboCause of deathCardiologyDiabetes mellitusType 2 Diabetes MellitusEndocrinologyDiseaseAlternative medicinePathologyDiabetes Treatment and ManagementHeart Failure Treatment and ManagementPancreatic function and diabetes
Effect of SGLT2 Inhibitors on Cardiovascular Outcomes Across Various Patient Populations | Litcius